Supplementary Methods
Immobilized metal ion affinity chromatography (IMAC). FldA and Fpr were purified separately using two 5 ml HisTrap ff crude columns (GE Healthcare in series that were equilibrated in buffer A (50 mM Tris-HCl pH 7.5 and 500 mM NaCl). The filtered protein fraction was applied to the columns and non-specifically bound proteins were eluted with buffer A containing 30 mM imidazole. Hereafter, elution of FldA and Fpr was carried out with buffer A containing 200 mM and 150 mM imidazole, respectively. The eluted proteins were then concentrated using centrifugal devices (Sartorius, Vivaspin 10 kDa MWCO), followed by desalting by employing a Sephadex G-25 column (GE-Healthcare) using buffer B (50 mM Tris-HCl, pH 7.5, 50 mM NaCl and 5% (v/v) glycerol) as eluent. Finally, purified FldA and Fpr was concentrated as described above and stored at -20°C. For the rapid small scale purification of the fusion proteins, five selfcast Ni 2+ -NTA (Qiagen, Hilden, Germany) columns with a 1.5 ml bed volume were used in parallel. The soluble protein fractions were incubated for 1 h on ice in the presence of FAD and FMN, each at a final concentration of 10 µM and then filtered (0.45µM). The filtered protein samples were 1:1 diluted with buffer C (100 mM Tris-HCl pH 7.5 and 300 mM NaCl) and applied to the Ni 2+ -NTA columns. Non-specifically bound proteins were removed by using buffer C containing 10 mM imidazole, whereas subsequent elution of the fusion proteins was carried out in buffer C containing 150 mM imidazole. The obtained elution fraction (~8 ml) for each fusion protein was concentrated to a volume of ~1 ml using centrifugal devices (MWCO of 30 kDa) and then desalted by gravity flow PD-10 columns (GE-Healthcare) in buffer B. Finally, the purified fusion proteins were concentrated as described above and stored at -20°C.
Determination of the protein concentration of the fusion constructs. Considering the various fusion proteins, both the FMN-containing FldA domain and FAD-containing Fpr domain
contribute to absorbance. It has previously been shown that the cumulative absorbance spectrum of Fpr and FldA measured in separate chambers of a tandem cuvette only marginally differs from the absorbance spectrum obtained after mixing the two redox proteins 1 , which demonstrates that major spectral changes do not occur when Fpr and FldA are allowed to interact. Therefore, for the calculation of the fusion protein concentration, the FldA extinction coefficient at 456 nm was determined first (8.040 M −1 cm −1 ) and added to the published  456 of Fpr (7.100 M −1 cm −1 ), which yields a combined  456 of 15.140 M −1 cm −1 for the fusion constructs. Table 1 in the main manuscript).
Supplementary Results

Supplementary
Supplementary Figure S2. ESI-MS analysis of selected fusion constructs.
To verify the molecular mass of selected fusion constructs, the purified proteins were dialyzed against ddH 2 O for 1 h (2 x 30 min, Scienova Microdialyzer 6 -8 kDa) and subjected to ESI-MS. ESI-MS was essentially performed as in 2 using a tandem hybrid mass spectrometer (QSTAR XL, Applied Biosystems, Darmstadt, Germany) equipped with an offline nanospray ion source. Mass spectra were typically measured in a mass range 700 -2500 m/z. The ESI-MS spectra were reconstructed using the deconvolution algorithm included in the analysis software (Applied Biosystems). The theoretical and measured average mass of the various fusion constructs are shown in table below.
Protein
Theoretical SDS-PAGE analysis of the AR fusion construct indicated an apparent MW of ~40 kDa (Fig. 1 , main manuscript), whereas its theoretical mass is 48.293 kDa. ESI-MS analysis of the AR construct revealed however a mass of 48.631 kDa, which demonstrates that truncation of the AR fusion protein had not occurred. A slight mass difference between the theoretical mass and the measured mass was observed, which can be explained by the presence of retained cofactor FMN (456.34 Da) and an additional oxidation (within mass accuracy ± 1.5 Da). The masses of the redox active constructs AR-P4 and RA-P5 determined by ESI-MS were found to be identical to their theoretical masses. Thus ESI-MS analysis confirmed the masses of the fusion constructs. It can therefore be excluded that the MW discrepancy observed for the AR fusion constructs during SDS-PAGE analysis is due to a loss of mass resulting from e.g. protein truncation. Supplementary Table S1 . 
